Exelon and Breastfeeding
It is not known whether it is safe for women who are nursing to take Exelon. Breastfeeding women are not likely to take this medication, however, since it is approved for treating Alzheimer's and Parkinson's -- conditions that don't typically occur in women of childbearing age. Since no studies have been conducted on Exelon and breastfeeding, the effects the drug could have on a nursing infant are also unknown.
It is not known whether Exelon® (rivastigmine tartrate) passes through breast milk in humans. Therefore, it is a good idea to talk with your healthcare provider before taking the drug if you are breastfeeding or plan to start breastfeeding. It should be noted that Exelon is approved only for treating Alzheimer's or Parkinson's dementia, conditions that are unlikely to occur in women of childbearing age.
No studies have been conducted on whether Exelon passes through breast milk in women. However, studies have shown that the drug passes through breast milk in rats. It is not known whether Exelon could have any negative effects on an infant if it does pass through breast milk in humans.
Talking With Your Healthcare Provider About Exelon and BreastfeedingYou should talk with your healthcare provider about Exelon and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Exelon and breastfeeding that is right for you.